DVL

DVL

DVL is a conserved eukaryotic protein family implicated in intracellular signaling and developmental patterning across metazoans. Originally identified through genetic screens in Drosophila and characterized in Caenorhabditis elegans and vertebrate models such as Mus musculus and Xenopus laevis, DVL proteins interface with multiple pathways governing cell fate, polarity, and morphogenesis. Research into DVL connects fields represented by institutions like the National Institutes of Health, the Howard Hughes Medical Institute, and journals such as Nature and Cell.

Definition and Nomenclature

The term denotes a small family of cytoplasmic signaling mediators historically named after mutants isolated in Drosophila melanogaster genetic screens conducted by developmental biologists working alongside laboratories at Cambridge University and Cold Spring Harbor Laboratory. Human paralogs are annotated in databases curated by UniProt and referenced in the Human Genome Project outputs produced by teams at the Wellcome Trust Sanger Institute. Nomenclature varies across species: vertebrate genomes list paralogs with numerical suffixes described in gene catalogs from Ensembl and the National Center for Biotechnology Information.

Biology and Molecular Function

DVL proteins act as intracellular transducers in cascades initiated by receptors such as members of the Frizzled family and co-receptors including LRP5 and LRP6. They participate in canonical signaling branches that stabilize β-catenin and regulate transcriptional programs via complexes that include TCF7L2 and CBP. In noncanonical contexts DVL interfaces with cytoskeletal regulators like Daam1 and motor proteins investigated in studies at Max Planck Institute and Stanford University. Cross-talk with pathways involving APC and GSK3B modulates processes analyzed in developmental paradigms from Zebrafish embryogenesis to Human organogenesis examined at research centers such as Harvard Medical School.

Clinical Significance and Disease Associations

Alterations in DVL expression or mutation are associated with congenital defects catalogued alongside conditions studied at Great Ormond Street Hospital and genetic repositories like the Deciphering Developmental Disorders project. Dysregulation of DVL-mediated signaling contributes to tumorigenesis in malignancies surveyed in clinical cohorts from Memorial Sloan Kettering Cancer Center and trials registered by National Cancer Institute consortia; implicated cancers include colorectal tumors with perturbations in APC/β-catenin axis and certain breast carcinomas analyzed at Mayo Clinic. DVL involvement appears in neurodevelopmental disorders discussed in publications from Johns Hopkins University and in fibrotic diseases researched at University College London and pharmaceutical programs at Pfizer and Roche.

Structural and Biochemical Properties

DVL proteins contain conserved domains such as the DIX domain characterized in structural studies from EMBL and the PDZ domain resolved by laboratories at MIT and ETH Zurich. High-resolution analyses using techniques developed at facilities like European Synchrotron Radiation Facility and Argonne National Laboratory revealed domain interfaces that mediate oligomerization and interaction with partners including Frizzled and Axin. Post-translational modifications—phosphorylation by kinases such as CK1 and ubiquitination regulated by E3 ligases like ITCH—alter DVL stability; these biochemical modifications have been profiled using mass spectrometry platforms from Thermo Fisher Scientific and proteomics pipelines at ProteomeXchange contributors.

Research Methods and Experimental Studies

Experimental approaches to study DVL span genetic, biochemical, and cell biological methods. Classic forward genetics performed in Drosophila and reverse genetics via CRISPR/Cas9 in Mus musculus and Danio rerio elucidate in vivo roles; these methods are paired with imaging modalities developed at NIH microscopy cores and confocal systems from Leica Microsystems. Biochemical assays include co-immunoprecipitation and reporter assays using TOPFlash/FOPFlash constructs, while single-molecule and cryo-EM techniques at centers like Riken and Max Planck Institute for Biochemistry define supramolecular assemblies. High-throughput screens for modulators employ compound libraries curated by Chemical Biology Consortium networks and readouts implemented in collaborations with Broad Institute and translational teams at Genentech.

Category:Proteins